ALFA Filings
Every announcement, straight from the exchange
Every Indo US Bio-Tech management change announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements with these filters
Indo Us Bio-Tech Limited appointed Bhagat & Associates as Statutory Auditor following Gautam N Associates' resignation. The change aligns with administrative restructuring of audit assignments.
Indo Us Biotech Limited appointed Mrs. Hemanshi Darsh Soni as an Additional Independent Director for a five-year term effective April 21, 2026. Simultaneously, Mrs. Neha Sachinbhai Patel resigned from her position as Non-Executive Independent Director on the same date. These changes reflect a routine board reorganization.
Mrs. Nehaben Sachinbhai Patel has resigned from her position as a Non-Executive Independent Director at Indo Us Bio-Tech Limited effective April 21, 2026. She cited personal and unavoidable reasons for her departure and confirmed there are no other material reasons. She holds no other directorships in listed entities.
Indo Us Bio-Tech Limited has appointed Mrs. Hemanshi Darsh Soni as an Additional Non-Executive Independent Director for a five-year term effective April 21, 2026. This appointment, subject to shareholder approval, strengthens the company's board governance and independent oversight.
Mrs. Nehaben Sachinbhai Patel resigned as an Independent Director of Indo Us Bio-Tech Limited effective April 21, 2026, citing personal reasons. The Board accepted her resignation during their meeting on the same date. She confirmed there are no other material reasons for her departure.
Indo Us Bio-Tech Limited announced the resignation of Mrs. Nehaben Sachinbhai Patel from her position as Non-Executive and Independent Director, effective April 21, 2026. The director cited personal and unavoidable reasons for her departure, confirming there are no other material reasons for the resignation.
Indo Us Bio-Tech Limited has appointed Mrs. Hemanshi Darsh Soni as an Additional Director (Non-Executive Independent) for a five-year term effective April 21, 2026. The appointment is subject to shareholder approval at the next Annual General Meeting. Mrs. Soni is not related to any of the company's directors or key managerial personnel.